Predictive and prognostic factors in malignant pleural mesothelioma
Author:
- 1 March 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 15 (2) , 127-130
Abstract
Predictive and prognostic factors are of great importance in patients with malignant pleural mesothelioma. In the following article, the recent knowledge about these factors is presented in order to determine the patients who may benefit most from current experimental therapies.Keywords
This publication has 33 references indexed in Scilit:
- Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesotheliomaLung Cancer, 2001
- Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristicsRespiratory Medicine, 2001
- Angiogenesis is an independent prognostic factor in malignant mesotheliomaBritish Journal of Cancer, 2001
- Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systemsThorax, 2000
- Expression of vascular endothelial growth factor in diffuse malignant pleural mesotheliomaVirchows Archiv, 1999
- Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesotheliomaLung Cancer, 1999
- Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group BChest, 1998
- Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.Journal of Clinical Oncology, 1998
- EVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMAThe Journal of Pathology, 1997
- Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and stagingCancer, 1993